Biktarvy, formally known as bictegravir, represents a effective single-tablet regimen for managing HIV infection. This formula unites three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by blocking the HIV's ability to multiply within the body, significantly reducing the viral burden. For many indiv